AU583272B2 - Coacervate system synthetic whole blood substitute - Google Patents

Coacervate system synthetic whole blood substitute

Info

Publication number
AU583272B2
AU583272B2 AU42941/85A AU4294185A AU583272B2 AU 583272 B2 AU583272 B2 AU 583272B2 AU 42941/85 A AU42941/85 A AU 42941/85A AU 4294185 A AU4294185 A AU 4294185A AU 583272 B2 AU583272 B2 AU 583272B2
Authority
AU
Australia
Prior art keywords
composition
hemoglobin
phase
coacervate
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42941/85A
Other languages
English (en)
Other versions
AU4294185A (en
Inventor
Bernard Ecanow
Charles S. Ecanow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthetic Blood Corp
Original Assignee
Synthetic Blood Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Blood Corp filed Critical Synthetic Blood Corp
Publication of AU4294185A publication Critical patent/AU4294185A/en
Application granted granted Critical
Publication of AU583272B2 publication Critical patent/AU583272B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
AU42941/85A 1984-04-27 1985-04-24 Coacervate system synthetic whole blood substitute Ceased AU583272B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60447684A 1984-04-27 1984-04-27
US604476 1984-04-27

Publications (2)

Publication Number Publication Date
AU4294185A AU4294185A (en) 1985-11-28
AU583272B2 true AU583272B2 (en) 1989-04-27

Family

ID=24419756

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42941/85A Ceased AU583272B2 (en) 1984-04-27 1985-04-24 Coacervate system synthetic whole blood substitute

Country Status (5)

Country Link
EP (1) EP0179879A1 (fr)
JP (1) JPS61501989A (fr)
AU (1) AU583272B2 (fr)
NO (1) NO855255L (fr)
WO (1) WO1985005035A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874742A (en) * 1981-01-05 1989-10-17 Synthetic Blood Corporation Synthetic whole blood and a process for preparing the same
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
CA1318589C (fr) * 1986-08-14 1993-06-01 Bernard Ecanow Systeme d'administration de medicament
JP2962731B2 (ja) * 1986-11-10 1999-10-12 バイオピュアー、コーポレーション 超純枠半合成代用血液
IL88095A0 (en) * 1987-10-23 1989-06-30 California Inst Of Techn Dna sequences,proteins and gene preparations
US6172039B1 (en) 1990-04-16 2001-01-09 Apex Bioscience, Inc. Expression of recombinant hemoglobin and hemoglobin variants in yeast
CN1102851C (zh) * 1993-06-04 2003-03-12 生物时间公司 类血浆溶液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343797A (en) * 1981-01-05 1982-08-10 Ecanow Charles S Synthetic whole blood and a method of making the same
EP0083469A2 (fr) * 1981-12-31 1983-07-13 Synthetic Blood Corporation Sang complet synthétique et son procédé de préparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539204A (en) * 1982-10-29 1985-09-03 Neomed Inc. Gelatin based synthetic blood and a method of making the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343797A (en) * 1981-01-05 1982-08-10 Ecanow Charles S Synthetic whole blood and a method of making the same
EP0083469A2 (fr) * 1981-12-31 1983-07-13 Synthetic Blood Corporation Sang complet synthétique et son procédé de préparation

Also Published As

Publication number Publication date
AU4294185A (en) 1985-11-28
WO1985005035A1 (fr) 1985-11-21
EP0179879A1 (fr) 1986-05-07
NO855255L (no) 1985-12-23
JPS61501989A (ja) 1986-09-11

Similar Documents

Publication Publication Date Title
US4963526A (en) Oral insulin and a method of making the same
US4849405A (en) Oral insulin and a method of making the same
Hunt et al. Synthesis and evaluation of a prototypal artificial red cell
WO1985005029A1 (fr) Insuline administree par voie orale et son procede de preparation
US4280996A (en) Fat emulsion for intravenous injection
US4963367A (en) Drug delivery compositions and methods
CA1197462A (fr) Systeme de transport d'oxygene fonctionnel
US4794000A (en) Coacervate-based oral delivery system for medically useful compositions
JP2746287B2 (ja) 脂質置換治療法
JPH0240644B2 (fr)
US5914311A (en) Method for reducing serum lipoprotein (A) concentration
US4343797A (en) Synthetic whole blood and a method of making the same
US4738952A (en) Substitute for human blood and a method of making the same
US4439424A (en) Synthetic whole blood
US4547490A (en) Synthetic whole blood and a method of making the same
KR20030053507A (ko) 동적-팽창 작용을 하는 폐계면활성제 조성물
AU583272B2 (en) Coacervate system synthetic whole blood substitute
EP0416575A2 (fr) Compositions pour la délivrance de médicaments à base de substances biologiques et procédé de préparation de telles compositions
US4853370A (en) Substitute for human blood and a method of making the same
EP0124527B1 (fr) Sang entier synthetique a base de gelatine et son procede de fabrication
JPS58502204A (ja) 合成全血およびその製造方法
US4612370A (en) Lipid-saccharide reaction products
US4874742A (en) Synthetic whole blood and a process for preparing the same
CA1253801A (fr) Analogue du sang humain et methode de production
JPH04300838A (ja) 人工赤血球および人工赤血球懸濁液